Vetter Development Services Rankweil is poised for expansion
Vetter’s Newest Clinical Manufacturing Site Successfully Completed its First Customer Fills
Next milestone for the site development is achieved - Positive feedback received from audits with more scheduled - Planned expansions will help meet increased customer demand
With the realization of the first successful customer fills, Vetter, a leading global Contract Development and Manufacturing Organization (CDMO) have reached another milestone at its new clinical manufacturing facility in Rankweil, Austria.
Further batches are already planned, and more customer projects are in the business pipeline. In addition, the site is being expanded to optimize processes and increase production capabilities.
About Vetter
Headquartered in Ravensburg, Germany, Vetter is a family-owned, global leading contract development and manufacturing organization (CDMO) with production facilities in Germany, Austria, and the United States. Currently employing more than 5,700 individuals worldwide, the company has long-term experience in supporting biotechnology and pharmaceutical customers both large and small.
Vetter services range from early-stage development support including clinical manufacturing to commercial supply and numerous packaging solutions for vials, syringes, and cartridges. As a leading solution provider, Vetter appreciates its responsibility to support the needs of its customers by developing devices that contribute to increased patient safety, convenience, and enhanced compliance. Great importance is also given to social responsibility including environmental protection and sustainability.
Leveraging free trade agreements and the benefit of sharing a border with the populous Chinese market, businesses in Quang Ninh are progressively increasing the global reach of their branded goods and products.
Within the context of high-level meetings between Vietnam and the Republic of Korea (RoK) over recent years, the leaders of both nations have consistently aimed to boost bilateral trade turnover to 100 billion USD by 2020, and subsequently by 2023. Despite these ambitions, the target has not been met. To realize this goal in the future, it will be essential to implement a range of synchronized solutions.